Gain Contingency, Patents Allegedly Infringed, Number, Revised

No definition available.

Name:	skin_GainContingencyPatentsAllegedlyInfringedNumberRevised
Namespace Prefix:	skin_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Gain Contingency, Patents Allegedly Infringed, Partial Denial Of Motion For Summary Judgement Of Non-Infringement, Number

+ References

No definition available.

+ Details

Name:	skin_GainContingencyPatentsAllegedlyInfringedPartialDenialOfMotionForSummaryJudgementOfNonInfringementNumber
Namespace Prefix:	skin_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Loss Contingency, Number Of Competing Motions

+ References

No definition available.

+ Details

Name:	skin_LossContingencyNumberOfCompetingMotions
Namespace Prefix:	skin_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of entity's patents that another entity has allegedly infringed.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483049/450-30-50-1

+ Details

Name:	us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 27
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482395/460-10-55-27

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_LitigationCaseAxis=skin_EdgeSystemsLLCVCartessaAestheticsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_SecuritiesClassActionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_LuvoMedicalTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_AestheticManagementPartnersInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_EMIRAmedUSALLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_SinclairPharmaUSIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_MedicreationsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies (Details)	Aug. 26, 2024 segment	Aug. 16, 2024 segment	Jul. 24, 2024 segment	Jul. 08, 2024 segment	May 06, 2024 segment	Jan. 16, 2024 competingMotion	Sep. 15, 2022 patent	Dec. 14, 2020 segment patent
Edge Systems LLC v. Cartessa Aesthetics, LLC
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number								5
Gain contingency, patents allegedly infringed, number, revised \| patent								4
Gain contingency, patents allegedly infringed, partial denial of motion for summary judgement of non-infringement, number \| patent							3
Securities Lass Action
Loss Contingencies [Line Items]
Loss contingency, number of competing motions \| competingMotion						3
Luvo Medical Technologies Inc
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number		5
Aesthetic Management Partners Inc.
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number				5
eMIRAmed USA, LLC
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number	5
Sinclair Pharma US, Inc
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number			5
Medicreations LLC
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number					12